跳至主要内容
临床试验/NCT06916611
NCT06916611进行中(未招募)不适用

Heart Failure With Preserved Ejection Fraction and Its Cardiac MR Characteristics of Different Subtypes

The Affiliated Hospital of Xuzhou Medical University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
500
试验地点
1
主要终点
Rate of Cardiovascular death

研究概览

简要总结

Using cardiac magnetic resonance imaging technology, the ejection fraction of heart failure (HFpEF) and different subtypes of cardiac magnetic resonance characteristics, and combined with the clinical characteristics and prognosis of the patient, explore the value of cardiac magnetic resonance in disease diagnosis, classification, treatment and prognosis, and provide new ideas for clinical practice.

详细描述

  1. Study Objectives To compare clinical characteristics among HFpEF patients with different comorbidity subtypes (hypertension, type 2 diabetes, renal insufficiency, obesity).

To identify distinct cardiac magnetic resonance (CMR) features associated with HFpEF and its comorbidity subtypes.

To evaluate prognostic differences (mortality, heart failure readmission, healthcare costs) across HFpEF subtypes. 2. Study Design Type: Single-center, prospective, observational cohort study. Duration: April 1, 2023 - December 31, 2026. Sample Size: 500 HFpEF patients, with ~200 patients per subgroup. 3. Data Collection Framework

Baseline Data:

Clinical Parameters:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age is 50 years old.
  • Cardiac color ultrasound shows an ejection fraction (EF) of 50% or more.
  • Symptoms / signs of heart failure and increased natriuretic peptide levels during hospitalization / visit (BNP 100 pg/mL or NT-proBNP 400 pg / mL).

排除标准

  • Severe liver and kidney insufficiency
  • Severe valvular heart disease (severe, severe severe) or known infiltrative or hypertrophic cardiomyopathy
  • Malignant tumors and severe hematological diseases
  • severe infection
  • Autoimmune system diseases

结局指标

主要结局

Rate of Cardiovascular death

时间窗: follow - up every 6 months; up to 24 - months

Rate of readmission of heart failure

时间窗: follow - up every 6 months; up to 24 - months

次要结局

  • Body Temperature(Baseline)
  • Blood Glucose Levels(Baseline)
  • Brain Natriuretic Peptide (BNP)(Baseline)
  • Glycated Hemoglobin (HbA1c)(Baseline)
  • Blood Pressure(Baseline)
  • Heart Rate(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Heart Failure With Preserved Ejection Fraction and... | 临床试验